218 related articles for article (PubMed ID: 9013942)
1. Plasmin-induced proteolysis of tenascin-C: modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering.
Gundersen D; Trân-Thang C; Sordat B; Mourali F; Rüegg C
J Immunol; 1997 Feb; 158(3):1051-60. PubMed ID: 9013942
[TBL] [Abstract][Full Text] [Related]
2. Tenascin suppresses CD3-mediated T cell activation.
Hibino S; Kato K; Kudoh S; Yagita H; Okumura K
Biochem Biophys Res Commun; 1998 Sep; 250(1):119-24. PubMed ID: 9735343
[TBL] [Abstract][Full Text] [Related]
3. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
[TBL] [Abstract][Full Text] [Related]
4. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
Lind SE; Smith CJ
Arch Biochem Biophys; 1993 Nov; 307(1):138-45. PubMed ID: 8239651
[TBL] [Abstract][Full Text] [Related]
5. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor.
Fibbi G; Caldini R; Chevanne M; Pucci M; Schiavone N; Morbidelli L; Parenti A; Granger HJ; Del Rosso M; Ziche M
Lab Invest; 1998 Sep; 78(9):1109-19. PubMed ID: 9759655
[TBL] [Abstract][Full Text] [Related]
6. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
[TBL] [Abstract][Full Text] [Related]
7. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
Vines DJ; Lee SW; Dichek DA; Ellis V
J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes.
Lijnen HR; Wagner EF; Collen D
Thromb Haemost; 1997 Feb; 77(2):362-7. PubMed ID: 9157597
[TBL] [Abstract][Full Text] [Related]
9. Suppression of type I collagenase expression by antisense RNA in melanoma cells results in reduced synthesis of the urokinase-type plasminogen activator receptor.
Durko M; Brodt P
Biochem Biophys Res Commun; 1998 Jun; 247(2):342-8. PubMed ID: 9642128
[TBL] [Abstract][Full Text] [Related]
10. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
Plesner T; Behrendt N; Ploug M
Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
[TBL] [Abstract][Full Text] [Related]
11. Modulation of cell-associated plasminogen activation by stromelysin-1 (MMP-3).
Ugwu F; Lemmens G; Collen D; Lijnen HR
Thromb Haemost; 1999 Sep; 82(3):1127-31. PubMed ID: 10494776
[TBL] [Abstract][Full Text] [Related]
12. Binding and activation of plasminogen at the surface of human keratinocytes.
Reinartz J; Batrla R; Boukamp P; Fusenig N; Kramer MD
Exp Cell Res; 1993 Sep; 208(1):197-208. PubMed ID: 8359216
[TBL] [Abstract][Full Text] [Related]
13. Urokinase-type plasminogen activator inhibits alpha 4 beta 1 integrin-mediated T lymphocyte adhesion to fibronectin independently of its catalytic activity.
Olivier P; Bieler G; Müller KM; Hauzenberger D; Rüegg C
Eur J Immunol; 1999 Oct; 29(10):3196-209. PubMed ID: 10540331
[TBL] [Abstract][Full Text] [Related]
14. Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid.
Webber MM; Waghray A
Clin Cancer Res; 1995 Jul; 1(7):755-61. PubMed ID: 9816042
[TBL] [Abstract][Full Text] [Related]
15. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
[TBL] [Abstract][Full Text] [Related]
16. The interaction of tenascin-C with fibronectin modulates the migration and specific metalloprotease activity in human mesothelioma cell lines of different histotype.
Giuffrida A; Scarpa S; Birarelli P; Modesti A
Int J Oncol; 2004 Sep; 25(3):745-50. PubMed ID: 15289878
[TBL] [Abstract][Full Text] [Related]
17. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM
Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828
[TBL] [Abstract][Full Text] [Related]
18. Vascular smooth muscle cells efficiently activate a new proteinase cascade involving plasminogen and fibronectin.
Houard X; Monnot C; Dive V; Corvol P; Pagano M
J Cell Biochem; 2003 Apr; 88(6):1188-201. PubMed ID: 12647301
[TBL] [Abstract][Full Text] [Related]
19. Insight into the profibrinolytic activity of dermatan sulfate: effects on the activation of plasminogen mediated by tissue and urinary plasminogen activators.
Castañon MM; Gamba C; Kordich LC
Thromb Res; 2007; 120(5):745-52. PubMed ID: 17270255
[TBL] [Abstract][Full Text] [Related]
20. The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation.
Kassam G; Le BH; Choi KS; Kang HM; Fitzpatrick SL; Louie P; Waisman DM
Biochemistry; 1998 Dec; 37(48):16958-66. PubMed ID: 9836589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
